US Stock MarketDetailed Quotes

HEPA Hepion Pharmaceuticals

Watchlist
  • 1.2900
  • -0.0100-0.77%
Trading May 20 11:51 ET
7.06MMarket Cap-104P/E (TTM)

Hepion Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.96%-40.89M
-87.63%-9M
10.36%-11.24M
-65.82%-12.44M
18.90%-8.21M
-11.97%-34.96M
35.01%-4.8M
-10.70%-12.53M
-45.08%-7.5M
-37.83%-10.13M
Net income from continuing operations
-15.94%-48.93M
-62.37%-11.06M
-23.16%-10.53M
29.29%-14.08M
-91.35%-13.26M
-28.96%-42.2M
29.94%-6.81M
7.79%-8.55M
-159.70%-19.91M
-14.28%-6.93M
Operating gains losses
--1.32M
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-13.34%67.13K
-33.62%12.27K
4.35%18.5K
-1.07%18.33K
-20.65%18.04K
-10.01%77.46K
-21.09%18.48K
-23.28%17.73K
-13.46%18.53K
25.28%22.73K
Deferred tax
---409.02K
----
----
----
----
--0
----
----
----
----
Other non cash items
-6.03%-440K
-225.00%-260K
-275.00%-140K
1.74%-88.43K
114.90%48.43K
-117.97%-414.99K
-111.11%-80K
-89.33%80K
-111.11%-90K
-1,183.31%-324.99K
Change In working capital
-5.76%2.97M
-205.41%-1.94M
80.71%-906.71K
-73.46%2.77M
168.67%3.05M
156.63%3.15M
146.18%1.84M
-9.45%-4.7M
3,754.41%10.45M
-93.69%-4.44M
-Change in prepaid assets
191.62%2.68M
-156.03%-812.39K
-59.68%478.94K
-81.24%523.93K
155.06%2.48M
120.41%917.31K
150.81%1.45M
136.41%1.19M
296.62%2.79M
-1,058.67%-4.51M
-Change in payables and accrued expense
-86.51%302.92K
-384.90%-1.13M
76.48%-1.38M
-70.64%2.25M
642.59%566.62K
310.30%2.25M
129.25%395.96K
-470.31%-5.89M
352.22%7.66M
104.01%76.3K
-Change in other current assets
-64.51%89.83K
-20.98%39.24K
--0
--0
-24.69%50.59K
0.12%253.1K
-24.16%49.66K
--68.54K
--67.74K
--67.17K
-Change in other current liabilities
63.28%-96.71K
18.92%-42.13K
98.65%-964
--0
23.03%-53.61K
-1.85%-263.38K
22.93%-51.96K
-4.12%-71.28K
42.56%-70.48K
---69.65K
Cash from discontinued investing activities
Operating cash flow
-16.96%-40.89M
-87.63%-9M
10.36%-11.24M
-65.82%-12.44M
18.90%-8.21M
-11.97%-34.96M
35.01%-4.8M
-10.70%-12.53M
-45.08%-7.5M
-37.83%-10.13M
Investing cash flow
Cash flow from continuing investing activities
-1.66%-14.3K
97.87%-348
2.58K
-829.83%-16.54K
0
89.21%-14.07K
-1,633,700.00%-16.34K
0
119.18%2.27K
0
Net PPE purchase and sale
-1.66%-14.3K
97.87%-348
--2.58K
-829.83%-16.54K
--0
89.21%-14.07K
-1,633,700.00%-16.34K
--0
119.18%2.27K
--0
Cash from discontinued investing activities
Investing cash flow
-1.66%-14.3K
97.87%-348
--2.58K
-829.83%-16.54K
--0
89.21%-14.07K
-1,633,700.00%-16.34K
--0
119.18%2.27K
--0
Financing cash flow
Cash flow from continuing financing activities
187.49%4.49M
243.27%4.49M
0
0
0
-106.27%-5.14M
-3.14M
0
0
-102.43%-2M
Net preferred stock issuance
--0
----
----
----
----
---3.14M
----
----
----
----
Proceeds from stock option exercised by employees
--4.49M
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
----
----
----
----
---2M
--0
--0
--0
---2M
Cash from discontinued financing activities
Financing cash flow
187.49%4.49M
243.27%4.49M
--0
--0
--0
-106.27%-5.14M
---3.14M
--0
--0
-102.43%-2M
Net cash flow
Beginning cash position
-43.96%51.19M
-67.40%19.28M
-57.44%30.52M
-45.73%42.99M
-43.96%51.19M
124.30%91.35M
-40.09%59.15M
-34.87%71.71M
-31.38%79.22M
124.30%91.35M
Current changes in cash
9.24%-36.41M
43.32%-4.51M
10.38%-11.23M
-66.09%-12.45M
32.28%-8.21M
-179.24%-40.11M
-7.71%-7.95M
-10.34%-12.53M
-39.93%-7.5M
-116.23%-12.13M
Effect of exchange rate changes
110.66%5.02K
288.17%8.97K
85.72%-3.99K
-6.57%-18.74K
492.74%18.78K
---47.14K
---4.77K
---27.96K
---17.58K
--3.17K
End cash Position
-71.12%14.79M
-71.12%14.79M
-67.40%19.28M
-57.44%30.52M
-45.73%42.99M
-43.96%51.19M
-43.96%51.19M
-40.09%59.15M
-34.87%71.71M
-31.38%79.22M
Free cash flow
-16.94%-40.9M
-87.01%-9M
10.38%-11.23M
-66.04%-12.45M
18.90%-8.21M
-11.55%-34.98M
34.79%-4.81M
-10.34%-12.53M
-44.75%-7.5M
-36.31%-10.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.96%-40.89M-87.63%-9M10.36%-11.24M-65.82%-12.44M18.90%-8.21M-11.97%-34.96M35.01%-4.8M-10.70%-12.53M-45.08%-7.5M-37.83%-10.13M
Net income from continuing operations -15.94%-48.93M-62.37%-11.06M-23.16%-10.53M29.29%-14.08M-91.35%-13.26M-28.96%-42.2M29.94%-6.81M7.79%-8.55M-159.70%-19.91M-14.28%-6.93M
Operating gains losses --1.32M------------------------------------
Depreciation and amortization -13.34%67.13K-33.62%12.27K4.35%18.5K-1.07%18.33K-20.65%18.04K-10.01%77.46K-21.09%18.48K-23.28%17.73K-13.46%18.53K25.28%22.73K
Deferred tax ---409.02K------------------0----------------
Other non cash items -6.03%-440K-225.00%-260K-275.00%-140K1.74%-88.43K114.90%48.43K-117.97%-414.99K-111.11%-80K-89.33%80K-111.11%-90K-1,183.31%-324.99K
Change In working capital -5.76%2.97M-205.41%-1.94M80.71%-906.71K-73.46%2.77M168.67%3.05M156.63%3.15M146.18%1.84M-9.45%-4.7M3,754.41%10.45M-93.69%-4.44M
-Change in prepaid assets 191.62%2.68M-156.03%-812.39K-59.68%478.94K-81.24%523.93K155.06%2.48M120.41%917.31K150.81%1.45M136.41%1.19M296.62%2.79M-1,058.67%-4.51M
-Change in payables and accrued expense -86.51%302.92K-384.90%-1.13M76.48%-1.38M-70.64%2.25M642.59%566.62K310.30%2.25M129.25%395.96K-470.31%-5.89M352.22%7.66M104.01%76.3K
-Change in other current assets -64.51%89.83K-20.98%39.24K--0--0-24.69%50.59K0.12%253.1K-24.16%49.66K--68.54K--67.74K--67.17K
-Change in other current liabilities 63.28%-96.71K18.92%-42.13K98.65%-964--023.03%-53.61K-1.85%-263.38K22.93%-51.96K-4.12%-71.28K42.56%-70.48K---69.65K
Cash from discontinued investing activities
Operating cash flow -16.96%-40.89M-87.63%-9M10.36%-11.24M-65.82%-12.44M18.90%-8.21M-11.97%-34.96M35.01%-4.8M-10.70%-12.53M-45.08%-7.5M-37.83%-10.13M
Investing cash flow
Cash flow from continuing investing activities -1.66%-14.3K97.87%-3482.58K-829.83%-16.54K089.21%-14.07K-1,633,700.00%-16.34K0119.18%2.27K0
Net PPE purchase and sale -1.66%-14.3K97.87%-348--2.58K-829.83%-16.54K--089.21%-14.07K-1,633,700.00%-16.34K--0119.18%2.27K--0
Cash from discontinued investing activities
Investing cash flow -1.66%-14.3K97.87%-348--2.58K-829.83%-16.54K--089.21%-14.07K-1,633,700.00%-16.34K--0119.18%2.27K--0
Financing cash flow
Cash flow from continuing financing activities 187.49%4.49M243.27%4.49M000-106.27%-5.14M-3.14M00-102.43%-2M
Net preferred stock issuance --0-------------------3.14M----------------
Proceeds from stock option exercised by employees --4.49M------------------0----------------
Net other financing activities -----------------------2M--0--0--0---2M
Cash from discontinued financing activities
Financing cash flow 187.49%4.49M243.27%4.49M--0--0--0-106.27%-5.14M---3.14M--0--0-102.43%-2M
Net cash flow
Beginning cash position -43.96%51.19M-67.40%19.28M-57.44%30.52M-45.73%42.99M-43.96%51.19M124.30%91.35M-40.09%59.15M-34.87%71.71M-31.38%79.22M124.30%91.35M
Current changes in cash 9.24%-36.41M43.32%-4.51M10.38%-11.23M-66.09%-12.45M32.28%-8.21M-179.24%-40.11M-7.71%-7.95M-10.34%-12.53M-39.93%-7.5M-116.23%-12.13M
Effect of exchange rate changes 110.66%5.02K288.17%8.97K85.72%-3.99K-6.57%-18.74K492.74%18.78K---47.14K---4.77K---27.96K---17.58K--3.17K
End cash Position -71.12%14.79M-71.12%14.79M-67.40%19.28M-57.44%30.52M-45.73%42.99M-43.96%51.19M-43.96%51.19M-40.09%59.15M-34.87%71.71M-31.38%79.22M
Free cash flow -16.94%-40.9M-87.01%-9M10.38%-11.23M-66.04%-12.45M18.90%-8.21M-11.55%-34.98M34.79%-4.81M-10.34%-12.53M-44.75%-7.5M-36.31%-10.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg